Amivantamab Plus Lazertinib Vs Osimertinib in First Line, Egfr-Mutant Advanced Nsclc: Patientrelevant Outcomes From Mariposa
Loading...
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Science inc
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Description
Keywords
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Volume
19
Issue
10
Start Page
S103
End Page
S104
Web of Science™ Citations
2
checked on Mar 17, 2026
Page Views
3
checked on Mar 17, 2026
